Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial (Q43822191)
Jump to navigation
Jump to search
scientific article published in December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial |
scientific article published in December 2001 |
Statements
1 reference
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial (English)
1 reference
G Frasci
1 reference
V Lorusso
1 reference
N Panza
1 reference
P Comella
1 reference
G Nicolella
1 reference
A Bianco
1 reference
G DeCataldis
1 reference
M Belli
1 reference
N Iannelli
1 reference
B Massidda
1 reference
V Mascia
1 reference
G Comella
1 reference
M De Lena
1 reference
1 December 2001
1 reference
1 reference
34 Suppl 4
1 reference
S65-9
1 reference
Identifiers
1 reference
1 reference